The Form Bio team, from L-R: co-CEO Andrew Busey; director of bioinformatics Brandi Cantarel; co-CEO Kent Wakeford; chief strategy officer Claire Aldridge; plus Colossal CEO Ben Lamm (Business Wire)

George Church’s wool­ly mam­moth re­vival biotech Colos­sal spins out com­pu­ta­tion­al bio out­fit

Colos­sal Bio­sciences has a some­what lofty goal — re­vive the wool­ly mam­moth. When the biotech launched in 2021, its CEO Ben Lamm com­pared its mis­sion to the Apol­lo pro­gram in an in­ter­view with CNN, equat­ing its as­pi­ra­tions to space ex­plo­ration, but not­ing that it could make oth­er break­throughs along the way, as Apol­lo did with GPS.

Now Colos­sal is shar­ing its ver­sion of the GPS, an AI plat­form that is meant to make man­ag­ing mas­sive datasets — com­mon­place in biotech to­day — more user-friend­ly and less code-heavy.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.